KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to 32.11%.

  • Idexx Laboratories' EBITDA Margin rose 95.00% to 32.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.34%, marking a year-over-year increase of 242.00%. This contributed to the annual value of 28.95% for FY2024, which is 102.00% down from last year.
  • Idexx Laboratories' EBITDA Margin amounted to 32.11% in Q3 2025, which was down 4.52% from 33.62% recorded in Q2 2025.
  • Idexx Laboratories' EBITDA Margin's 5-year high stood at 33.62% during Q2 2025, with a 5-year trough of 20.81% in Q2 2022.
  • Its 3-year average for EBITDA Margin is 30.28%, with a median of 31.15% in 2023.
  • In the last 5 years, Idexx Laboratories' EBITDA Margin plummeted by 1,057bps in 2022 and then spiked by 1,058bps in 2023.
  • Idexx Laboratories' EBITDA Margin (Quarterly) stood at 24.86% in 2021, then surged by 247bps to 27.34% in 2022, then declined by 13bps to 27.21% in 2023, then rose by 21bps to 27.42% in 2024, then soared by 95bps to 32.11% in 2025.
  • Its EBITDA Margin was 32.11% in Q3 2025, compared to 33.62% in Q2 2025 and 31.70% in Q1 2025.